Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lysine hydrochloride is an injectable formulation of the essential amino acid L-lysine, primarily indicated for the treatment of nervous system disorders. As a fundamental component of protein synthesis, lysine is crucial for growth, tissue repair, and the production of enzymes, hormones, and antibodies. In the context of neurological health, it is utilized to supplement amino acid levels, supporting metabolic processes and potentially aiding in the recovery of neural function. The product is manufactured and marketed by Hainan Hailing Chemipharma in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lysine hydrochloride.